SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 20-F - Notification of inability to timely file Form 20-F:
SEC Accession No. 0001213900-24-037801
Filing Date
2024-04-30
Accepted
2024-04-30 16:01:13
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-30

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING ea0204876-nt20f_nlspharma.htm NT 20-F 21553
  Complete submission text file 0001213900-24-037801.txt   22634
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: NT 20-F | Act: 34 | File No.: 001-39957 | Film No.: 24896968
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)